The company may well be considering intrathecal delivery already because the third candidate in their ASO+CPP drug pipeline is indicated for a neurological disease.
With respect to treatments for Alzheimer’s, here’s a link to an older Alzforum article on the various drug delivery methods that are being used to access the brain.
I like the last idea of an implanted polymer capsule. PolyNovo has been working on an implantable polymer drug delivery device for the treatment of chronic disease. It would be exciting to see it deliver a PYC drug!
PYC Price at posting:
6.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)